Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543).

VanderBeek, Brian L; Jain, Nieraj

Re: Ludwig et al.: Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States (Ophthalmology. 2020;127:535-543).

VanderBeek, Brian L; Jain, Nieraj.

Afiliação

VanderBeek BL; Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics & Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Leonard Davis Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Jain N; Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: nieraj.jain@emory.edu.

Ophthalmology ; 127(5): e35-e36, 2020 05.

Article em En | MEDLINE | ID: mdl-32327143

Assuntos

Degeneração Macular; Doenças Retinianas; Humanos; Poliéster Sulfúrico de Pentosana; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google